Results 191 to 200 of about 1,021,233 (291)

Evaluating Value Beyond Efficacy: A Meta-Analytic Assessment of Inclisiran's Cost-Effectiveness in Cardiovascular Prevention. [PDF]

Healthcare (Basel)
Maștaleru A, Zouri M, Leon MM, Popescu G, Zouri N, Tamba BI, Cumpăt CM.   +6 more
europepmc   +1 more source

Cost‐utility analysis of nusinersen–risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model

British Journal of Clinical Pharmacology, EarlyView.
Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić, Ivana Stević, Elvira Meni Maria Gkrinia, Dinko Vitezić, Slobodan Janković   +4 more
wiley   +1 more source

Deriving monetary value of quality-adjusted life years through life extension from the value of a statistical life. [PDF]

Sci Rep
Tanizawa Y, Ito K, Takashima R.
europepmc   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

British Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Determinants of healthcare expenditures: evidence from Türkiye's healthcare system. [PDF]

Front Public Health
Diğer H, Çebi Karaaslan K, Köstekçi A, Göv A.   +3 more
europepmc   +1 more source

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden, Miriam G. Mooij, Matthijs de Hoog, Saskia N. de Wildt   +3 more
wiley   +1 more source

Parental choice of private tuition: Valuing attention, judging quality and navigating access in England's underregulated supplementary education market

British Educational Research Journal, EarlyView.
Abstract Private supplementary education is burgeoning worldwide, and over 25% of English children have received private tutoring. The neoliberalisation of education and parents' responsibilisation for children's attainment have driven market growth, but not all can afford to participate.
Sarah L. Holloway, Sam Whewall, Helena Pimlott‐Wilson   +2 more
wiley   +1 more source

Cost-Effectiveness of Once Weekly Rezafungin for the Treatment of Invasive Candidiasis in the United Kingdom. [PDF]

Mycoses
Muszbek N, Angdembe A, Garcia-Vidal C, Bielicka I, Abrams KR, Tolley K, Ruhnke M, Lebmeier M, Hawkins N, Manamley N, Dickerson S.   +10 more
europepmc   +1 more source

Understanding international students' agency in developing employability: Case study of a post‐1992 university in the United Kingdom

British Educational Research Journal, EarlyView.
Abstract Employability remains a critical issue for international students in the United Kingdom. This study adopts the Employability Agency Framework proposed by Pham et al. to explore how a group of international students actively exercised their agency to enhance their employability during their Master's studies in the United Kingdom.
Hoang Nguyen, Ming Cheng
wiley   +1 more source

Default mode network activity is related to efficiency in a combined motion error and gambling task. [PDF]

Sci Rep
Chernov GV, Mel'nikov MY, Belianin AV, Rudych PD, Bezmaternykh DD, Shakhzadayev RM.   +5 more
europepmc   +1 more source